JP2025041635A5 - - Google Patents
Info
- Publication number
- JP2025041635A5 JP2025041635A5 JP2024207280A JP2024207280A JP2025041635A5 JP 2025041635 A5 JP2025041635 A5 JP 2025041635A5 JP 2024207280 A JP2024207280 A JP 2024207280A JP 2024207280 A JP2024207280 A JP 2024207280A JP 2025041635 A5 JP2025041635 A5 JP 2025041635A5
- Authority
- JP
- Japan
- Prior art keywords
- amyloid beta
- pharmaceutical composition
- amyloid
- peptide
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962789114P | 2019-01-07 | 2019-01-07 | |
| US62/789,114 | 2019-01-07 | ||
| JP2021539599A JP2022516574A (ja) | 2019-01-07 | 2020-01-06 | 新規ペプチドとその使用 |
| PCT/US2020/012323 WO2020146236A1 (en) | 2019-01-07 | 2020-01-06 | Novel peptides and uses thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539599A Division JP2022516574A (ja) | 2019-01-07 | 2020-01-06 | 新規ペプチドとその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025041635A JP2025041635A (ja) | 2025-03-26 |
| JP2025041635A5 true JP2025041635A5 (https=) | 2025-09-08 |
Family
ID=71520880
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539599A Pending JP2022516574A (ja) | 2019-01-07 | 2020-01-06 | 新規ペプチドとその使用 |
| JP2024207280A Pending JP2025041635A (ja) | 2019-01-07 | 2024-11-28 | 新規ペプチドとその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539599A Pending JP2022516574A (ja) | 2019-01-07 | 2020-01-06 | 新規ペプチドとその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220064214A1 (https=) |
| EP (1) | EP3908307A4 (https=) |
| JP (2) | JP2022516574A (https=) |
| KR (1) | KR20220004618A (https=) |
| CN (2) | CN113853382A (https=) |
| AU (2) | AU2020207203A1 (https=) |
| CA (1) | CA3125552A1 (https=) |
| IL (1) | IL284666A (https=) |
| WO (1) | WO2020146236A1 (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4966848A (en) * | 1988-02-08 | 1990-10-30 | The General Hospital Corporation | Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase |
| US5223421A (en) * | 1989-10-25 | 1993-06-29 | The General Hospital Corporation | Identification of methionine Nα-acetyltransferase |
| US5688489A (en) * | 1995-09-15 | 1997-11-18 | Resolution Pharmaceuticals, Inc. | Non-receptor mediated imaging agents |
| US6777388B1 (en) * | 1998-08-21 | 2004-08-17 | Clf Medical Technology Acceleration Program, Inc. | Leptin-related peptides |
| US6660843B1 (en) * | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| US20030077740A1 (en) * | 2001-03-05 | 2003-04-24 | Schubert David R. | Presenilin/Crk binding polypeptides (PCBP) and methods of use thereof |
| US8129334B2 (en) * | 2006-03-31 | 2012-03-06 | The Regents Of The University Of California | Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory |
| JP2013526518A (ja) * | 2010-05-13 | 2013-06-24 | ザ ユニバーシティ オブ ケンタッキー リサーチ ファウンデーション | Ｍｃｉおよびアルツハイマー病の処置 |
| CN106456799B (zh) * | 2014-06-03 | 2020-05-22 | 江苏佳瑞生物技术有限公司 | 肽-药物偶联物 |
-
2020
- 2020-01-06 AU AU2020207203A patent/AU2020207203A1/en not_active Abandoned
- 2020-01-06 US US17/420,927 patent/US20220064214A1/en active Pending
- 2020-01-06 CN CN202080017996.0A patent/CN113853382A/zh active Pending
- 2020-01-06 WO PCT/US2020/012323 patent/WO2020146236A1/en not_active Ceased
- 2020-01-06 EP EP20738687.1A patent/EP3908307A4/en active Pending
- 2020-01-06 KR KR1020217024603A patent/KR20220004618A/ko active Pending
- 2020-01-06 CN CN202210033802.7A patent/CN114437173A/zh active Pending
- 2020-01-06 CA CA3125552A patent/CA3125552A1/en active Pending
- 2020-01-06 JP JP2021539599A patent/JP2022516574A/ja active Pending
-
2021
- 2021-07-06 IL IL284666A patent/IL284666A/en unknown
-
2024
- 2024-11-28 JP JP2024207280A patent/JP2025041635A/ja active Pending
-
2026
- 2026-01-14 AU AU2026200229A patent/AU2026200229A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ecroyd et al. | Crystallin proteins and amyloid fibrils | |
| Takeda et al. | Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders | |
| JP6029280B2 (ja) | Ｄ−ペプチドを有する抗−アミロイドβ−ペプチド抗体を製造するための組成物 | |
| Ikeda et al. | Corticobasal degeneration with primary progressive aphasia and accentuated cortical lesion in superior temporal gyrus: case report and review | |
| JP2012520852A5 (https=) | ||
| JP2022524078A (ja) | 深部組織浸透性ｃ５阻害剤としてのジルコプラン | |
| JP2017532068A5 (https=) | ||
| US10323082B2 (en) | Treatment of tauopathies by passive immunization targeting the N-terminal projection domain of tau | |
| WO2010044464A1 (ja) | 改変アミロイドβペプチド | |
| JP2025041635A5 (https=) | ||
| US20180170983A1 (en) | New Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Mild Cognitive Impairment | |
| CN104277092B (zh) | 用于预防和/或治疗老年性痴呆的β片层阻断肽 | |
| EP1392347B1 (en) | Preventing cell death using segments of neural thread proteins | |
| JP2025506472A (ja) | 抗アルファシヌクレイン治療的ワクチン | |
| JP2022516574A5 (https=) | ||
| JP2022121359A (ja) | シナプスおよび樹状突起棘の喪失を逆転させるための複数のケモカインレセプターの経口用ペプチドアンタゴニスト | |
| Giladi et al. | Freezing phenomenon, the fifth cardinal sign of parkinsonism | |
| JP2024534901A5 (https=) | ||
| EP1381627B1 (en) | Polypeptides derived from amyloid precursor peptide (app) and their uses | |
| EP4595972A1 (en) | Peptide for treating or preventing 4r tauopathy | |
| AU2002302239B2 (en) | Method of preventing cell death using segments of neural thread proteins | |
| AU2002308327B2 (en) | Method of preventing cell death using antibodies to neural thread proteins | |
| Yamanouchi et al. | Ubiquitin-immunoreactive granular inclusions in neuronal migration disorders | |
| EP1541166A1 (en) | Preventing cell death using segments of neural thread proteins | |
| WO2024179606A1 (zh) | 一种glp-1化合物的医药用途 |